User Fees

CHPA’s President & CEO, Scott Melville, released a statement in response to the FDA Safety and Landmark Advancement (FDASLA) Act of 2022.

While this week both the House and Senate are on recess, last week the Senate HELP Committee began the process of meeting to discuss and ultimately pass the Prescription Drug User Fee Act (PDUFA).

The Senate HELP Committee will vote next Wednesday, January, 12, on whether to send Dr. Robert Califf’s nomination as FDA commissioner to the Senate floor for a confirmation vote.

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Just prior to the 4th of July holiday, the House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Appropriations Subcommittee released its FY 2022 Report.

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.